The number six on our top 10 pharmaceutical companies in the United States is Abbot Laboratories. Headquartered in the Abbott Park Business Center in Lake Bluff, Illinois, Abbott Laboratories, founded in 1888, engages in the sale of medical devices, diagnostics, branded generic medicines, and nutritional products. Abbott’s products are used to diagnose and monitor diseases such as HIV, hepatitis, cancer, heart failure, and metabolic disorders.
In 2019, Abbot Laboratories brought in annual revenue of $31.9 billion and had around 107,000 employees in December of the same year. In 2020, Abbot’s first-quarter worldwide sales of $7.7 billion increased by 2.5 % on a reported basis and 4.3 % on an organic basis. The company’s second-quarter 2020 worldwide sales of $7.3 billion decreased 8.2 % on a reported basis and 5.4 % on an organic basis, which excludes the impact of foreign exchange. The Third-quarter 2020 worldwide sales of $8.9 billion increased 9.6 % on a reported basis and 10.6 % on an organic basis, which excludes the impact of foreign exchange.
Abbot Laboratories in the first to the third quarter of 2020 reported a total worldwide sale of $23.9 billion.
Formerly known as Applied Molecular Genetics Inc, Amgen was established in Thousand Oaks, California in 1980. Currently, this American multinational biopharmaceutical company is one of the largest independent biotechnology companies in the world.
In 2019, Amgen generated $23.4 billion in revenue. The company in the first quarter of 2020 generated $6.2 billion in revenue – an increase of 11 % in comparison to the first quarter of 2019. Despite the impact of the COVID-19 pandemic, total revenues increased 6% to $6.2 billion in comparison to the second quarter of 2019. This increase in the second quarter of 2020 was driven by higher unit demand, offset partially by lower net selling prices. Total revenues for the third quarter of 2020 increased 12 % to $6.4 billion in comparison to the third quarter of 2019 driven by higher volume growth, partially offset by lower net selling prices and the effects of the COVID-19 pandemic.
Amgen generated $18.8 billion in revenue in the first three quarters of 2020.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California. Gilead Sciences doesn’t just operate in the United States alone, but on three continents: North America, Europe, and Australia.
After originally focusing heavily on anti-viral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, the multinational biopharmaceutical company expanded its product line after acquiring two smaller pharma companies that concentrated on pulmonary diseases treatment.
Gilead generated $22.1 billion in revenue in 2019 and had 11,800 employees. Total revenues for the first quarter of 2020 were $5.5 billion, an increase of 5 % compared to the same period in 2019. This demonstrates Gilead’s continued progress and highlights the strength of the company’s underlying business. The second-quarter 2020 revenue of $5.1 billion compared to $5.7 billion for the same periods in 2019 reflected a 10 % decrease in sales, with Gilead’s hepatitis C drug franchise contributing to most of the decline. Total revenues for the third quarter of 2020 were $6.6 billion, up 17%, compared to $5.6 billion, for the same period in 2019.
Gilead Sciences from the first to the third quarter of 2020 generated $17.2 billion in revenue.
Known simply as Lilly, the American pharmaceutical company, founded in 1876, has her headquarters in Indianapolis, Indiana, with offices in 18 other countries. Lilly was the first company to mass-produce penicillin, insulin, and the Salk polio vaccine.
They are currently the largest manufacturer of psychiatric medications and produce Prozac (fluoxetine), Dolophine (methadone), Cymbalta (duloxetine), and Zyprexa (olanzapine), and their products are sold in approximately 125 countries.
In 2019, Lilly generated $22.3 billion in revenue. The first quarter 2020 revenue of $5.86 billion increased by 15 % in comparison to the first quarter of 2019. In the second and third quarter of 2020, Lilly announced revenues of $5.49 billion and $5.74 billion respectively. Despite a 2 % decline in revenue in the second quarter of 2020, Lilly achieved several important R&D milestones, including three FDA approvals for new medicines, positive phase 3 results for several important clinical programs, and continued progress in the company’s quest to develop medicines for patients with COVID-19.
Eli Lilly and Company in the first three quarters of 2020 generated $17.1 billion in revenue, making it number 9 on our list of top 10 pharmaceutical companies in the United States.
Biogen Inc. is a Massachusetts-based American multinational biotechnology company. Founded in 1978 by a small group of visionary scientists, the company discovers, develops manufactures, and markets innovative therapies for global patient populations with neurological and neurodegenerative diseases. Biogen also manufactures and commercializes biosimilars of advanced biologics. Today, Biogen is one of the oldest independent biotechnology companies in the world.
In 2019, Biogen generated $14.4 billion in revenue. The total revenue for the first quarter of 2020 grew 1 % to $3.53 billion from $3.49 billion in the same quarter in 2019. In the second quarter of 2020, the company generated approximately $3.68 billion, a 2% increase versus the second quarter of 2019. The third quarter 2020 revenue of $3.38 billion showed a 6% decrease versus the third quarter of 2019, inclusive of a 1% unfavorable currency impact.
Biogen generated 10.59 billion in the first three quarters of 2020 making it number 10 on our list of top 10 pharmaceutical companies in the U.S.
Comments2
Hi, I would like to know more about you guys, like what you do exactly and where you guys located .
Best Regards,
Marc
Thanks for reaching out to us. You can visit the link https://www.pharmapproach.com/about-us/ to know more about us.